Mizuho Financial Group Down over 6%, On Track for Largest Percent Decrease Since June 2020 — Data Talk
Mizuho Financial Group Inc. Sponsored ADR (MFG) is currently at $3.16, down $0.20 or 6.01%
--Would be lowest close since Aug. 21, 2023, when it closed at $3.12
--On pace for largest percent decrease since June 11, 2020, when it fell 6.11%
--Currently down three consecutive days; down 12.77% over this period
--Worst three day stretch since the three days ending March 9, 2020, when it fell 14.94%
--Down 8.2% month-to-date
--Up 11.19% year-to-date; on pace for best year since 2015, when it rose 18.82%
--Down 79.09% from its all-time closing high of $15.10 on Jan. 22, 2007
--Up 46.2% from 52 weeks ago (Nov. 9, 2022), when it closed at $2.16
--Down 13.48% from its 52-week closing high of $3.65 on Sept. 22, 2023
--Up 46.2% from its 52-week closing low of $2.16 on Nov. 9, 2022
--Traded as low as $3.14; lowest intraday level since Aug. 21, 2023, when it hit $3.09
--Down 6.55% at today's intraday low; largest intraday percent decrease since March 10, 2023, when it fell as much as 7.43%
All data as of 12:57:45 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 08, 2023 13:15 ET (18:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast